IDH2 and astrocytoma (excluding glioblastoma): This resulted in establishing more specific diagnostic categories, namely "astrocytoma, IDH-mutant" and "oligodendroglioma, IDH-mutant and 1p/19q-codeleted." The molecular stratification yielded more precise prognostic data and facilitated the customization of therapy strategies [28].